Is herd immunity closer than we think? aamc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aamc.org Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
FORT COLLINS, Colo., April 20, 2021 /PRNewswire/ Cytocom, Inc. (Cytocom), a leading biopharmaceutical company creating next generation immune therapies built around proprietary discovery and development technologies, today announced that Stephen Wilson, Ph.D., has joined the company as its Head of Global Innovations, effective April 19, 2021. Dr. Wilson arrives at Cytocom after spending nearly 25 years at the La Jolla Institute for Immunology (LJII) where he was active in biomedical research and served as the research facility s chief operating officer.
As Head of Global Innovation for Cytocom, Dr. Wilson will help identify new indications for Cytocom s existing pipeline of assets designed to rebalance the body s immune system and restore homeostasis and lead efforts to develop a global network of researchers and scientists to collaborate with Cytocom in new applications for its AIMS™ (Advanced Immunomodulating Multi-Receptor System) dr
The
La Jolla Light presents this continuing series of online activities to undertake on your computer or tablet during your quarantine quandary.
Lectures & learning
• UC San Diego presents
“A Deep Look Into Earth Day 2021: The Changing Climate of Our Natural World” at noon Thursday, April 22, online. UCSD researchers will offer a range of perspectives on how the climate, human activities and other forces interconnect with the natural world. Free.
• Citizens’ Climate Lobby presents the
“Wild & Scenic” film festival beginning at 7 p.m. Thursday, April 22, online. The event, which runs through April 27, features 20 award-winning films about nature, activism, conservation, climate change, wildlife, environmental justice and agriculture. $25 ($20 with discount code CCLSDN); $15 for students.
Shape-shifting Ebola virus protein exploits human RNA to change shape eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
10 Apr 2021 / 09:00 H.
(Adds outside comment, details throughout)
By Carl O Donnell
April 1 (Reuters) - Pfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months.
The shot also showed early signs of preventing disease in a small subset of study volunteers in South Africa, where a concerning new variant called B.1.351 is circulating.
Although lower than the stunning 95% efficacy result reported from its 44,000-person clinical trial in November, overall efficacy of 91.3% shows the vaccine to be a powerful tool against an evolving virus. The virus now has more transmissible forms and those that have been shown to evade antibody protection in lab studies and real-world clinical trials.